5 Results for "

GNF-5

" in MedChemExpress (MCE) Product Catalog:
Products (5)

5 Results for "GNF-5" in MCE Product Catalog:

4
4 Cited Publications
Cat. No.: HY-15738
CAS No.: 778277-15-9
Purity:  99.95%
Target:  

Bcr-Abl

Research Areas:  

Cancer

GNF-5, the N-hydroxyethyl carboxamide analog of GNF-2, is an orally active Bcr-Abl inhibitor. GNF-5 has Bcr-Abl inhibition activity with an IC50 value of 0.22 µM. GNF-5 has good favorable pharmacokinetic properties. GNF-5 can be used for the research of kinds of cancer including chronic myelogenous leukemia (CML) and breast cancer .
loading...
    loading...
Cat. No.: HY-111860
Target:  

SNIPERs Bcr-Abl

Research Areas:  

Cancer

SNIPER(ABL)-013, conjugating GNF5 (ABL inhibitor) to Bestatin (IAP ligand) with a linker, induces the reduction of BCR-ABL protein with a DC50 of 20 μM .
loading...
    loading...
Cat. No.: HY-111861
CAS No.: 2222355-77-1
Target:  

SNIPERs Bcr-Abl

Research Areas:  

Cancer

SNIPER(ABL)-024, conjugating GNF5 (ABL inhibitor) to LCL161 derivative (IAP ligand) with a linker, induces the reduction of BCR-ABL protein with a DC50 of 5μM .
loading...
    loading...
Cat. No.: HY-111852
CAS No.: 778277-37-5
Synonyms: PROTAC ABL binding moiety 2
Research Areas:  

Cancer

GNF5-amido-Me, the GNF5 (ABL inhibitor) based moiety, binds to IAP ligand via a linker to form SNIPER .
loading...
    loading...
Cat. No.: HY-111854
Target:  

SNIPERs Bcr-Abl

Research Areas:  

Cancer

SNIPER(ABL)-015, conjugating GNF5 (ABL inhibitor) to MV-1 (IAP ligand) with a linker, induces the reduction of BCR-ABL protein with a DC50 of 5 μM .
loading...
    loading...